Call for Abstracts

International Neuropsychological Society
Denver, Colorado, USA | February 5-8, 2020
INS President: Vicki Anderson, PhD
Program Co-Chairs: Miriam Beauchamp, PhD, & Ozioma Okonkwo, PhD
Continuing Education Chair: Melissa Lamar, PhD
Abstract submissions are closed

Submission Opens: Friday, June 7th, 2019
Submission Closed: Sunday, September, 1st, 2019 – extended

Message from Miriam Beauchamp & Ozioma Okonkwo 2020 INS Program Committee Co-Chairs:


The theme for the 2020 Annual Meeting in Denver is: Neuropsychology in the Era of Precision Medicine. Precision medicine, broadly defined, refers to the ways in which treatments can be optimized to align with the particular characteristics of an individual and to reflect person-specific variability in biology, environment, and lifestyle. From its early days as a discipline, neuropsychology has embraced the importance of considering “the individual” and the utility of an assessment approach that is flexible and adaptable. As contemporary medicine enters this new frontier marked by deeper appreciation for the ways in which an individual’s genetic and environmental makeup shape their susceptibility to disease and response to treatment, it is important for our discipline to renew this long-standing perspective and highlight the key role that neuropsychologists play in precision medicine.

We welcome abstracts consistent with this theme, such as those that examine the ways that neuropsychology fosters the prediction of diseases and response to treatment, or studies that utilize methodological approaches and data from genomics, big data, electronic health records, and single case studies, or material relevant to the role that neuropsychologists play in multidisciplinary teams. As always, we also encourage submissions that offer unique insights into the cognitive and affective neuroscience of healthy and disease states, innovations in behavioral measurement, and state-of-the-art treatment and rehabilitation approaches.

We are very excited to be returning to Denver, The Mile-High City! We hope you will join us for what promises to be a dynamic scientific program, and to enjoy the exhilarating potpourri of offerings in arts, culture, and sports that Denver so readily provides!

  • INS will be providing Child Care Services!
  • TRAVEL GRANTS: students from low-to-middle income nations may apply for one of 4 travels awards. See this announcement for more details.

Program Highlights

Among our Keynote Speakers for the 2020 Annual Meeting will be Vicki Anderson, PhD, INS President, and
  • Nicholas Allen, PhD, Professor and Director, Center for Digital Mental Health at the University of Oregon
  • Dana Small, PhD, Professor and Director, Modern Diet and Physiology Research Center at the Yale University School of Medicine
  • Sonia Lupien, PhD, Professor in the Department of Psychiatry at the University of Montreal
  • Urvashi Shah, PhD, Department of Neurology at the King Edward Memorial Hospital, Mumbai, India
  • Nim Tottenham, PhD, Professor of Psychology, Department of Psychology, Columbia University, New York City, New York
  • Tomas Paus, PhD, Director of the Population Neuroscience & Developmental Neuroimaging Program at the Holland Bloorview Kids Rehabilitation Hospital, and Professor of Psychology and Psychiatry at the University of Toronto
Invited symposia include: Case Studies vs. Big Data, chaired by Jon Evans, PhD, Exercise and Cognition, chaired by Glenn Smith, PhD, a panel discussion on chronic traumatic encephalopathy chaired by Michael Alosco, PhD, and participation of past INS presidents in a planned symposium, chaired by Russell Bauer, PhD. There will also be a very special symposium honoring the life and works of Dr. Donald Stuss, chaired by Brian Levine, PhD



Important Submission Guidelines:

  • The abstract submission deadline was Sunday, September, 1st, 2019 at exactly 11:59pm U.S. Eastern Time (-0400 UTC). Any submissions that were still in draft status will not be considered. No additional submissions will be accepted (there is not a late-breaking submission category for this meeting).
  • By submitting, authors commit to be available to present on the date and time they are assigned. Accepted abstracts may be scheduled at any time during the four-day meeting at the discretion of the Program Chair.
  • There is no limitation on the number of submissions, but authors are asked to use discretion because submitting multiple abstracts is likely to create scheduling problems.
  • The body of submitted abstracts may not exceed 2200 characters, including spaces. Paper or Poster submissions must be organized under these headings: 1. Objective, 2. Participants and Methods, 3. Results, 4. Conclusions.
  • All submissions must consist of original work. Abstracts submitted to other meetings or that have been previously published should not be submitted and will not be considered.
  • All research, results, and conclusions must be final at the time of submission. Submissions that are promissory in nature will not be considered.
  • Case reports may be submitted, but the abstract should clearly describe the uniqueness of the case and how it addresses critical knowledge gaps in the field.
  • Submissions will be published exactly as received. Please proofread carefully before finalizing your submission. Once the deadline has passed, we reserve the right to decline to accommodate any requests for corrections to typos or other entry errors made by the author during submission.
  • All submissions will be peer reviewed by the Program Committee. The Program Committee Chairs will make the final decision on all submissions.
  • Accepted abstracts must be presented by the presenting author or an officially designated representative. The corresponding author must formally communicate any changes in the presenting author to Any author who plans to attend the meeting must register and pay the appropriate meeting registration fee.
  • Abstracts that are accepted and presented at the meeting will be published in an online, supplemental issue of the Journal of the International Neuropsychological Society: JINS (to be published after conclusion of the meeting).


Authors may submit abstracts for Poster or Paper consideration, or a complete Symposium Proposal.

  1. Poster sessions: Posters have proven to be an effective and popular method for communication of scientific information, providing a more intimate forum for informal discussion than is permitted by regular platform presentations. Poster presenters should stay with their poster for the duration of the poster session (approximately 60-90 minutes) and are encouraged to upload a PDF handout to the meeting app.
  2. Paper sessions: Paper sessions are topical oral sessions that are arranged at the discretion of the INS Program Committee Chairs. Four to six outstanding abstracts are typically selected for each paper session. Each abstract is allotted approximately 12-20 minutes (depending on the number of presenters per session) for oral presentation and audience discussion. A moderator is assigned to each session to introduce speakers, help solve any problems, encourage discussion, and keep the session running on time through strict adherence to stated time limits.
  3. Symposia sessions: Symposia are topical platform sessions dealing with specific issues in clinical neuropsychology. Symposia are submitted as integrated session proposals (each consisting of an overall proposal and 4-5 participating abstracts) that have been pre-organized by a single symposium chair. Symposium proposals that do not meet the criteria listed below will not be considered.
    • A complete symposium proposal consists of an overall Symposium Proposal, plus four to five Participating Symposium Abstracts (submitted by the symposium chair) Symposium Chairs will use the Participating Symposium Abstract form found HERE. We highly recommend filling out this form prior to beginning the submission process.
    • Symposium abstracts should be closely linked and integrated. Symposia are allotted approximately 90 minutes, so each participating abstract should be given approximately 15-20 minutes. Each symposium can include a discussant, and should include a dedicated question and answer period. In the case of a symposium that expresses divergent views on a controversial topic, two longer debate-style talks may also be appropriate.
    • The symposium chair is SOLELY responsible for submitting a complete symposium proposal as described.
Submission Categories:

Each abstract must be submitted under one of the categories listed below.

ADHD/Attentional Functions
Assessment/Psychometrics/Methods (Adult)
Assessment/Psychometrics/Methods (Child)
Autism Spectrum Disorders/Intellectual Disability
Cognitive Intervention/Rehabilitation
Cognitive Neuroscience
Concussion/Mild TBI (Adult)
Concussion/Mild TBI (Child)
Dementia (Alzheimer’s Disease)
Dementia (Non-AD)
Drug/Toxin-Related Disorders (including Alcoholism)
Emotional and Social Processes
Executive Functions/Frontal Lobes
Forensic Neuropsychology/Malingering/Noncredible Presentations
Genetics/Genetic Disorders
Inclusion and Diversity/Multiculturalism
Infectious Disease/Encephalitis/Meningitis (including HIV/AIDS)
Language and Speech Functions/Aphasia
Learning Disabilities/Academic Skills
Medical/Neurological Disorders/Other (Adult)
Medical/Neurological Disorders/Other (Child)
Memory Functions/Amnesia
Mild Cognitive Impairment (MCI)
Mood & Anxiety Disorders
Movement and Movement Disorders
Multiple Sclerosis/ALS/Demyelinating Disorders
Prematurity/Low Birth Weight/In Utero Teratogen Exposure
Stroke/Cerebrovascular Injury & Disease (Adult)
Stroke/Cerebrovascular Injury & Disease (Child)
TBI (Moderate-Severe, Adult)
TBI (Moderate-Severe, Child)
Visuospatial Functions/Neglect/Agnosia

Submit Online at

Notification of acceptance will be made on/after Monday, October 7th 2019

Questions regarding abstract submission? Contact